Inspire Advisors »

Crispr Therapeutics shares owned by Inspire Advisors

Quarter-by-quarter ownership of Crispr Therapeutics (CRSP) shares owned by Inspire Advisors from 13F filings

Historical chart of Inspire Advisors investment in Crispr Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Crispr Therapeutics held by Inspire Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Crispr Therapeutics by Inspire Advisors

Quarter filed Position value Share count Share price at filing
2025-09-30 $898k 14k 64.81
2025-06-30 $704k 15k 48.64
2025-03-31 $459k 14k 34.03

More positions owned by Inspire Advisors

Northern Lts Fd Tr Iv Inspire Intl Etf (WWJD)
Northern Lts Fd Tr Iv Inspire Tactical (RISN)
Northern Lts Fd Tr Iv Inspire Corp Bd (IBD)
Northern Lts Fd Tr Iv Inspire Sml/ Mid (ISMD)
Northern Lts Fd Tr Iv Inspire 500 Etf (PTL)
Northern Lts Fd Tr Iv Inspire 100 Etf (BIBL)
Wisdomtree Tr Floatng Rat Trea (USFR)
Northern Lts Fd Tr Iv Inspire Fidelis (FDLS)
Invesco Exch Traded Fd Tr Ii Sr Ln Etf (BKLN)
Spdr Series Trust Portfli High Yld (SPHY)
Pgim Etf Tr Actv Hy Bd Etf (PHYL)
Pimco Etf Tr Sr Ln Active Etf (LONZ)
Global X Fds 1-3 Month T-bill (CLIP)
Etfs Gold Tr Physcl Gold Shs (SGOL)
Northern Lts Fd Tr Iv Inspire Momentum (GLRY)

View all positions for Inspire Advisors

Top funds holding Crispr Therapeutics

ARK Investment Management
BlackRock
Capital Research and Management Company - Division 3
Orbis Allan Gray
State Street Corporation
T. Rowe Price Investment Management
UBS Group
Vanguard Group
Sumitomo Mitsui Trust Holdings
Nikko Asset Management Americas
Geode Capital Management
Susquehanna International
Sr One Capital Management
Citadel Advisors
FMR

View all funds holding Crispr Therapeutics